RAPID relative to TAP, MCIT, and TCET
Published on: 28/04/2026
Discover how MCIT, TCET, TAP, and RAPID have shifted reimbursement expectations for MedTech.
Payer CoverageEvidence Planning
CMS Is Proposing to Eliminate the NTAP Alternative Pathway. Here's What MedTech Innovators Need to Know.
Published on: 28/04/2026
CMS may eliminate the NTAP Alternative Pathway. Learn how this policy shift impacts Breakthrough Devices, reimbursement strategy, and MedTech adoption.
Payer CoverageEvidence Planning
How Product Development Can Be Influenced by U.S. Reimbursement Mechanics
Published on: 04/11/2025
Learn how U.S. reimbursement mechanics—coding, coverage, and payment—should shape MedTech product design, trials, and launch strategies.
Payer CoverageEvidence Planning
Is an NCD the Right Move for Your Technology? Lessons from CMS’s Final Decision on Renal Denervation
Published on: 29/10/2025
Learn when to pursue a National Coverage Determination (NCD) and what CMS’s renal denervation decision means for MedTech reimbursement and evidence strategy.
Payer CoverageEvidence PlanningCommercialization
